Medical school honored with diversity, equity & inclusion award | Washington University School of Medicine in St. Louis
Racial and health equity, inclusion threaded through school’s mission
Racial and health equity, inclusion threaded through school’s mission
Datopotamab deruxtecan demonstrated comparable intracranial activity and safety in pretreated patients with NSCLC with or without brain metastases.
Can metformin use be linked to a lower risk of myeloproliferative neoplasms? Find out from this groundbreaking study.
The treatment of childhood acute lymphoblastic leukemia (ALL) has reached overall survival rates exceeding 90%. The present and future challenges are to cure the remainder…
The 29th Congress of the European Hematology Association (EHA) will be held in Madrid, Spain, and online, from June 13-16, 2024. This meeting will bring…
Michael Parry was diagnosed with pancreatic cancer at the age of 59. Fortunately, his disease was detected early – and after surgery and chemotherapy, he…
The 29th Congress of the European Hematology Association (EHA) will be held in Madrid, Spain, and online, from June 13-16, 2024. This meeting will bring…
Neoadjuvant nivolumab/chemotherapy, followed by surgery and adjuvant nivolumab, significantly improved EFS in stage III N2 and stage III non-N2 NSCLC.
In a phase 2 trial, all 42 patients with locally advanced mismatch repair–deficient rectal cancer achieved clinical complete response with dostarlimab.
Isatuximab plus VRd produced a statistically significant improvement in PFS vs VRd in newly diagnosed, transplant-ineligible multiple myeloma.
Annals of Surgical Oncology – Retroperitoneal sarcomas are a complex and heterogenous group of tumors. An approach to these tumors should be guided by a…